Recent randomized controlled trials covering several hundred patients with approximately 15 year follow up have documented that biologic repair of subchondral lesions for patients with osteoarthritis and osteonecrosis is a viable alternative to total knee arthroplasty. 

Please join CERVOS Co-founder Harlan Adler, alongside Dr. Jeff Chabot and renowned surgeons, Dr. Anil Ranawat, Dr. Alberto Gobbi, and Dr. Ignacio Dallo, to learn the latest advancements in knee joint preservation and how you can incorporate the insights from this research into your practice with CERVOS proprietary tools and techniques.